Image Source : ThePrint
Acquisition Overview
Genpharmasec Ltd has completed the acquisition of a 70% equity stake in Derren Healthcare Private Limited, marking a strategic leap into pharmaceutical manufacturing.
* The deal was executed through a Share Purchase Agreement and a Share Subscription cum
Shareholders Agreement
* Acquisition completed in phases over one year, finalized on March 11, 2024
* Total cost of acquisition: approximately ₹176.4 million
Strategic Rationale and Expansion Goals
* Derren Healthcare specializes in generics, finished formulations, CRO and CDMO services
* Genpharmasec aims to leverage DHPL’s 40,000 sq. ft. facility with an annual capacity of 8.64 million vials and ampules
* Plans include expansion into pre-filled syringes and tapping international regulatory approvals
Market Impact and Future Outlook
* The acquisition aligns with Genpharmasec’s long-term diversification strategy
* Expected to unlock synergies and enhance global competitiveness
Sources: Business Standard, The Hindu BusinessLine, Genpharmasec Exchange Filing
Advertisement
Advertisement